O'Loughlin Steve has filed 10 insider transactions across 2 companies since March 2025.
Most recent transaction: a grant/award of 9500 shares of CNS Pharmaceuticals, Inc. ($CNSP) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | CNS Pharmaceuticals, Inc. | $CNSP | O'Loughlin Steve | Chief Financial Officer | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 620,290 | 9999.99% | 1.53% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 1666 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 3333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 8833 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.03% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 13333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.04% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 3333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 107463 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.36% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 256438 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.85% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 253123 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.84% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | O'Loughlin Steve | Chief Financial Officer | D | Stock Option (Right to Buy) | 59066 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.20% |